Results 291 to 300 of about 5,917,232 (403)

Latest Progress on Tuberculosis and HIV Co‐Infection: A Closer Look at People of Different Ages

Advanced Therapeutics, EarlyView.
Tackling the problem of tuberculosis (TB) and human immunodeficiency virus (HIV) co‐infection is a serious global health concern affecting people of all ages. This review presents the characteristics of both diseases, current treatment and diagnostic guidelines, associated problems, innovations in disease management, and overall effects on global ...
Anna Yusuf Aliyu, Oluwatoyin A. Adeleke
wiley   +1 more source

Plin5: A potential therapeutic target for type 2 diabetes mellitus. [PDF]

Diabetol Metab Syndr
Wei M, Wang Y, Zhang Y, Qiao Y.
europepmc   +1 more source

Molecular analyses of the vasopressin type 2 receptor and aquaporin-2 genes in Brazilian kindreds with nephrogenic diabetes insipidus

, 1999
Juliane L. Rocha, Eitan Friedman, Wolfanga L. Boson, Ayrton Custódio Moreira, Bárbara Figueiredo, Bernardo Liberman, Luiz de Lacerda, R Sandrini, Hans Graf, Sonia Martins, Márcia Puñales, Luiz Marco   +11 more
openalex   +1 more source

Plasmatic homocyst(E)ine and folate are related to arterial blood pressure in type 2 diabetes mellitus [PDF]

, 1998
Paolo Fiorina
openalex   +1 more source

Nanoparticles Combining Host‐Directed Therapeutics and Antibiotics to Boost Bacterial Killing and Overall Survival of Zebrafish Embryos Infected with Mycobacterium Marinum

Advanced Therapeutics, EarlyView.
This study investigates the combination of host‐directed therapeutics (HDT) with antibiotics in a single polymeric micelle based on polypept(o)ides for the therapy of Mycobacterium tuberculosis (Mtb) and ‐marinum (Mm) infections. When the HDT and antibiotic are co‐encapsulated, it significantly reduces bacterial burden in cells and improves overall ...
Gabriela Schäfer, Dongdong Bi, Federico Fenaroli, Andrew M. Thompson, Anno Saris, Matthias Barz   +5 more
wiley   +1 more source

Effect of echocardiography on prognosis in patients with type 2 diabetes mellitus. [PDF]

PLoS One
Jiang Z, Chen JH, Zhang LJ, Zheng YP, Qiu SH.   +4 more
europepmc   +1 more source

From the FDA: Avandia approved to treat type 2 Diabetes [PDF]

, 1999

openalex   +1 more source

Biomedical Application of Cold Plasma: Navigating Through Plasma Types and Devices by Antimicrobial Effectiveness and Tissue Tolerance

Advanced Therapeutics, EarlyView.
Cold plasma devices (J‐Plasma, Piezo Brush PZ3, Plasma Care) generate unique reactive species that penetrate tissues differently, enabling biofilm eradication while preserving tissue health. This study uncovers plasma‐device interactions with biofilms and surfaces, highlighting tailored applications for precision medicine and infection control ...
Thomas P. Thompson, Amanda Connelly, Sean Kelly, Ross M. Duncan, Jordanne‐Amee Maybin, Carla McDonnell, Autumn Melvage, Laura A. McClenaghan, Aikaterini Dedeloudi, Dimitrios A. Lamprou, Thomas P. Schaer, Paula Bourke, Noreen J. Hickok, Brendan F. Gilmore, Theresa A. Freeman   +14 more
wiley   +1 more source

Attenuated metabolic and increased renal effects of angiotensin II (ang II) in early type 2 diabetes mellitus (NIDDM) [PDF]

, 1997
Danilo Fliser
openalex   +1 more source

Role of gut microbiota in type 2 diabetes pathophysiology

EBioMedicine, 2020
M. Gurung, Zhipeng Li, H. You, R. Rodrigues, D. Jump, A. Morgun, N. Shulzhenko   +6 more
semanticscholar   +1 more source